Key Questions for Adolescent Psychiatric Evaluation Prior to SSRI Medication
When evaluating adolescents for mood disorders prior to prescribing medications like fluoxetine, clinicians should use a structured approach that includes specific screening questions for depression, suicidality, and comorbid conditions.
Depression Screening Questions
Core Mood Assessment
- "Have you ever felt so upset that you wished you were not alive or wanted to die?" 1
- "Did you ever do something that you knew was so dangerous that you could get hurt or killed by doing it?" 1
- "Did you ever hurt yourself or try to hurt yourself?" 1
- "Did you ever try to kill yourself?" 1
- "Did you ever think about or try to commit suicide?" 1
Mood Changes and Symptoms
- Ask about distinct periods of mood changes associated with sleep disturbances and psychomotor activation 1
- Assess for irritability rather than depressed mood as the main manifestation in adolescents 1
- "Aside from [already stated non-mental health concern], how have you been doing?" 1
- "What kinds of things have been on your mind or stressing you lately?" 1
- "How have things been going with [school, friends, parents, sports]?" 1
Validated Screening Tools
Recommended Screening Instruments
- Patient Health Questionnaire-9: Modified for Teens (PHQ-9) with a cut-point of 11 (sensitivity 89.5%, specificity 77.5%) 1
- Patient Health Questionnaire-2 (PHQ-2) with a cut score of 3 (sensitivity 73.7%, specificity 75.2%) 1
Suicide Risk Assessment
Suicide Intent Evaluation
- Assess suicide plans: "If you were to kill yourself, how would you do it?" 1
- Determine if there are firearms in the home 1
- Evaluate the family's response to suicidal thoughts 1
- Assess motivating feelings (attention-seeking, desire to change relationships, wish to rejoin deceased relatives, escape from intolerable situations, revenge) 1
Risk Factors for Suicide
- Previous suicide attempts 1
- Male gender 1
- Increasing age 1
- Living alone (runaway, homeless, isolated) 1
- Attempts with methods other than ingestion or superficial cutting 1
- Steps taken to avoid detection 1
Bipolar Disorder Screening
Bipolar Symptoms
- Screen for distinct, spontaneous periods of mood changes with sleep disturbances and psychomotor activation 1
- Assess for family history of mood disorders 1
- Evaluate symptoms of irritability, reckless behaviors, or increased energy 1
- Look for manic grandiosity and irritability that present as marked changes in mental/emotional state 1
Pre-Medication Assessment
Treatment Considerations
- For moderate to severe depression, combination treatment with medication and psychotherapy is recommended 2
- Fluoxetine is the first-line SSRI for adolescents with major depressive disorder 2, 3
- Initial dosing for adolescents should be 10 mg daily for 1 week, then increased to 20 mg daily 3
- Weekly monitoring during the first 4 weeks of treatment is essential 2
Important Clinical Pearls
Diagnostic Pitfalls
- Manic-like symptoms of irritability and emotional reactivity may be found in multiple conditions, including disruptive behavior disorders, PTSD, and pervasive developmental disorders 1
- Behavioral and emotional reactions to psychosocial stressors may be mistaken as symptoms of an underlying biological illness 1
- Adolescents may disclose information about suicidality on self-report that they deny in person 1
Confidentiality Considerations
- Although confidentiality is important in adolescent health care, safety takes precedence over confidentiality for adolescents at risk to themselves or others 1
- Explain to the adolescent that confidentiality has limits when safety is concerned 1
Follow-up Planning
- Plan for weekly monitoring during the first 4 weeks of treatment 2
- Use standardized symptom rating scales to track progress 2
- Monitor for adverse effects, particularly suicidal ideation/behavior and activation syndrome 2
By using this structured approach to psychiatric evaluation, clinicians can thoroughly assess adolescents' mood and behavior before initiating SSRI treatment, ensuring appropriate diagnosis and treatment planning while prioritizing patient safety.